Home › Hodgkin Lymphoma › Texas › Houston

Pag-aaral pangklinika para sa Hodgkin Lymphoma sa Houston, TX

14 pag-aaral para sa Hodgkin Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Houston (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

Nagre-recruitPhase 1

Houston Methodist Hospital, Houston
Texas Children's Hospital, Houston

Edad 12 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06176690

CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

Nagre-recruitPhase 1

Houston Methodist Hospital, Houston
Texas Children's Hospital, Houston

Edad 12 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT02917083

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Texas Children's Hospital, Houston

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05615636

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

Nagre-recruitPhase 1/2

Research Site, Houston

Edad 12 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06137144

Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies

Nagre-recruitPhase 1

The University of Texas M. D. Anderson Cancer Center, Houston

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07444632

Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL

Nagre-recruitPhase 2

UT MD Anderson, Houston

Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07551583

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

Nagre-recruitPhase 1/2

M D Anderson Cancer Center, Houston

Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT05092451

Personalized NK Cell Therapy in CBT

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 15 hanggang 80 · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT02727803

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

M.D. Anderson Cancer Center, Houston
Texas Children's Hospital - Baylor Medical Center, Houston

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

Nagre-recruitPhase 1

Harris Health System - Ben Taub General Hospital/Smith Clinic, Houston
Houston Methodist Hospital, Houston
Texas Children's Hospital, Houston
at 1 pa

Lahat ng edad · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT04664179

A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo

MD Anderson Cancer Center, Houston

Edad 1 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT05355051

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

Nagre-recruitPhase 1

Harris Health System (includes ben Taub General Hospital and Smith), Houston
Houston Methodist Hospital, Houston
Texas Children's Hospital, Houston

Lahat ng edad · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT01555892

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Nagre-recruitPhase 1

Texas Children's Hospital/Baylor College of Medicine, Houston

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Pag-aaral para sa Hodgkin Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.